Don’t Get Hung Up On Gene Synthesis
Markus co-founded Synthace after working as a Research Associate in Synthetic Biology at University College London where he developed novel biosynthesis methods using pathway engineering. Prior to UCL,...
View Article5 Things You Need to Know About the Organism Industry
An industrial revolution is in the making. Biotechnology has touched almost every aspect of our lives over the past few decades. Food, pharma, power, manufacturing — you name it and biotech has...
View ArticleWhat U.K. Companies Are Traveling 5,400 Miles to SynBioBeta SF 2014?
A few years ago the United Kingdom selected synthetic biology as one of the Eight Great Technologies that will fuel economic growth for the country, provide avenues to boost exports, and receive seed...
View ArticleAntha to Code Experiments in Biology
Measure, pipette, mix, repeat. No doubt performing experiments in biotechnology are mundane tasks. In addition, the samples being handled are often in microscopic amounts and sensitive to the slightest...
View ArticleSynthace and Dow AgroSciences Announce Automated Bio-engineering Collaboration
Industrial engineering is difficult enough. Now imagine the challenges of bio-engineering, where your factories are living cells, with all of the thousands upon millions of interacting factors...
View ArticleMultifactorial Collaboration: Synthace & Merck Team up to Develop...
Biological therapeutics are the way of the future. Targeted antibodies, replacement enzymes, carefully crafted DNA – we have barely begun to see the changes that these possibilities will bring. But...
View ArticleSynthace Partners with Microsoft to bring Antha to Azure
LONDON, 6 April 2016 – Synthace Ltd., a London based technology company developing Antha, a high level language and operating system for working with biology, today announced it has entered into a...
View Article